{
"@context": "https://schema.org",
"@type": "Article",
"headline": "Federal Court: No Evidence that Allergan’s Textured Breast Implants Had a Higher Incidence of Cancer Than Other Manufacturers’ Implants",
"url": "https://www.lexblog.com/2023/01/19/federal-court-no-evidence-that-allergans-textured-breast-implants-had-a-higher-incidence-of-cancer-than-other-manufacturers-implants/",
"identifier": {
"@type": "PropertyValue",
"name": "LexBlog Library record",
"value": "LEX-WK-M5W62FAS",
"url": "https://www.lexblog.com/lib/M5W62FAS/"
},
"datePublished": "2023-01-19T05:00:00-05:00",
"dateModified": "2023-01-31T13:52:53-05:00",
"author": {
"@type": "Person",
"name": "Andrew Tauber"
},
"sourceOrganization": {
"@type": "Organization",
"name": "Drug & Device Law Blogging Team"
},
"organizationScope": "at-publication",
"isPartOf": "Drug & Device Law",
"about": "Banking, Finance and Securities · Health Care and Life Sciences",
"sourceUrl": "https://www.druganddevicelawblog.com/?p=41275",
"sourceStability": "may-move"
}